SUMMIT, N.J.–(BUSINESS WIRE)–ETFMG, a leading thematic ETF issuer behind the world’s largest cannabis ETF, MJ, the ETFMG Alternative Harvest ETF (NYSE Arca: MJ), has declared a $12,124,000 quarterly dividend, which equates to $0.28 cents per share. Across 2020, investors in MJ received a cumulative $16,404,000 in quarterly dividend payouts. This quarter’s dividend projects an annualized yield of 8.17%,¹ or 7.42% after deducting the Fund’s 0.75% expense ratio. The dividend will be paid June 18, 2020 to shareholders of record as of the close of business, June 16, 2020.

MJ Cash Distribution

• Ex-Date: June 15, 2020
• Record Date: June 16, 2020
• Payable Date: June 18, 2020

Performance

Fund Inception: 12/2/2015* Expense Ratio: 0.75%

Performance data quoted represents past performance and does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost. Current performance of the Funds may be lower or higher than the performance quoted. Performance data current to the most recent month end is available on www.etfmg.com.

About ETFMG

ETFMG is a provider of exchange-traded funds (ETFs), founded in 2014 with a vision of developing innovative thematic ETFs that provide investors unique exposure to new markets. Today, the ETFMG fund line up provides access to a diverse collection of global themes and is comprised of 75% first to market products. We turn portfolio management strategies into successful ETFs by partnering with market segment experts to bring long-term growth opportunities to investors. ETFMG funds are proof as to the power of the ETF wrapper and that thematic products can have a place in investors’ portfolios. For more information, please visit www.etfmg.com.

For more information on MJ, please visit www.etfmg.com/MJ.

MJ is the largest cannabis ETF in the world and the first U.S. listed ETF to target the global cannabis industry directly. The Fund provides investors unrivaled exposure to this constantly evolving sector which continues to see medicinal advancements, regulatory changes and M&A activity, highlighting the long-term, outsized investment opportunity in the cannabis industry.

Carefully consider the Fund’s investment objectives, risk factors, charges and expenses before investing. This and additional information can be found in the Fund’s statutory and summary prospectus, which is available on www.etfmg.com or may be obtained by calling 1-844-383- 6477. Read the prospectus carefully before investing.

*On December 26, 2017, the Fund’s investment objective and principal investment strategy were substantially revised; therefore, the performance and average annual total returns shown for periods prior to December 26, 2017 is likely to have differed had the Fund’s current investment strategy been in effect during those periods. The Fund’s prior investment objective sought to provide investment results that corresponded to the performance of the Solactive Latin America Real Estate Index, which tracked equities with primary listings in the Latin America region that derived most of their income from real estate and real estate services.

Investing involves risk, including the possible loss of principal. Shares of any ETF are bought and sold at market price (not NAV), may trade at a discount or premium to NAV and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Narrowly focused investments typically exhibit higher volatility.

The possession and use of marijuana, even for medical purposes, is illegal under federal and certain states’ laws, which may negatively impact the value of the Fund’s investments. Use of marijuana is regulated by both the federal government and state governments, and state and federal laws regarding marijuana often conflict. Even in those states in which the use of marijuana has been legalized, its possession and use remains a violation of federal law. Federal law criminalizing the use of marijuana pre-empts state laws that legalizes its use for medicinal and recreational purposes. Cannabis companies and pharmaceutical companies may never be able to legally produce and sell products in the United States or other national or local jurisdictions.

The fund is distributed by ETFMG Financial LLC.